Background: The availability and effectiveness of decision aids (DAs) on early abortion
| INTRODUCTION
As we have described previously, 1 women in the United States value receiving quality information [2] [3] [4] and support 5 when making decisions about early abortion. [6] [7] [8] [9] The two recommended methods, surgical and medical abortion, are both highly effective, safe and acceptable, yet differ across several aspects (eg duration, bleeding and cramping profile, where the abortion takes place, follow-up visit requirements). 10 According to a recent national survey of abortion providers, 11 both methods are available in a majority of abortion facilities, and among those facilities that offer only the medical option, most are located in areas also served by those that offer surgical abortion. 11 Recent changes to the US Food and Drug Administration regulations for mifepristone-misoprostol medical abortion are also anticipated to expand access to women. 12 Given the potential availability of both methods, and that they are similarly effective yet encompass very different processes, women's preferences and circumstances are paramount to their method choice.
Decision aids are tools designed to support patients to compare medically appropriate options and make informed decisions based on their preferences and quality evidence. 13 They enable standardized, patient-centred and balanced information provision and have been shown to improve patients' knowledge, participation in decision making and the alignment between their choices and their values in a range of clinical settings. 13 Decision aids are particularly relevant for the early abortion context given the prevalence of biased information about abortion, 14 relatively poor knowledge about the safety and consequences of abortion among the general public 15, 16 and the diminishing access to qualified abortion providers 17 who often serve as an important source of trusted information. 16 Moreover, because primary care providers sometimes have insufficient knowledge 18 and training 19 in early abortion methods, and counselling is not always well received from abortion providers, 20 integrating a consistent, high-quality decision aid may help health professionals across disciplines to better support women's decision making process. Even in areas where there may not be ready access to both methods, a decision aid may enable women to develop accurate expectations about the method that will be used and may also empower women as consumer advocates. Despite the potential utility of a decision aid on early abortion methods, we lack knowledge on the availability, quality and impact of existing decision aids on this topic.
The most recent Cochrane review of decision aids 13 and two other systematic reviews 21, 22 identified a single study evaluating an early abortion method decision aid, 23 which is no longer available to the public.
However, none of these reviews assessed the quality of identified decision aids. Additionally, because these reviews included only randomized controlled trials, whether other decision aids have been developed and evaluated using non-randomized study designs or developed and evaluated but not published in the scientific literature is unknown. What also remains unclear is the availability and quality of decision aids that have not undergone evaluation, including those developed by entities without specialist expertise in decision aid design (eg abortion clinics).
Such decision aids may be more easily accessed by the general public and thus more likely to be the first-line source of information.
The two objectives of this study were (i) to conduct a systematic review to identify, appraise and evaluate the impact of early abortion method decision aids described in the scientific literature, and (ii) to conduct an environmental scan of the grey literature to identify and appraise other early abortion method decision aids developed in the United States.
| METHODS
Study methods are described in detail in a published study protocol 1 and summarized below.
| Systematic review (Part I)
We registered the systematic review protocol on 12 February 2015 with the International Prospective Register of Systematic Reviews (CRD42015016717), and this reporting adheres to the PRISMA methodology. 24 
| Inclusion and exclusion criteria
We included studies if they were randomized controlled trials or non-randomized, cohort, case-control, before-and-after, interrupted time series or repeated-measures studies. 25 They must have included women eligible for and facing a decision between medical and surgical abortion (as defined by trialists), and collected patientor observer-reported data on the impact of an early abortion method decision aid on women's decision making processes or outcomes.
Our primary outcome was decision quality, defined as the extent to which a patient's decision is informed and based on personal values.
26-28
The decision aid must have met the definition adopted in the 
| Screening process
The screening and full review process of Internet pages and apps is described in full in the protocol. 1 We had planned to screen both titles and abstracts of all articles after duplicate entries were removed, 32 but ultimately opted to screen only titles unless further clarification from the abstract was needed. This screening approach has been shown to be as precise and more efficient than screening both titles and abstracts. 33 The primary reviewer (KD) classified each article as "potentially eligible" or "ineligible" for inclusion and, for articles classified as "ineligible," recorded the most salient reason. We had planned that the secondary reviewer (RT) would independently screen random samples of 10% of the titles and/or abstracts in each classification (ie "potentially eligible" and "ineligible"). However, because the primary reviewer only identified 12 "potentially eligible" studies (see Results), the second reviewer independently screened all of these studies (in addition to the 10% of "ineligibles"). The reviewers' classifications matched exactly. The same process was used for full-text review.
| Data extraction
The primary and secondary reviewers used a customized form to independently extract data on the study design, participant characteristics, decision aid characteristics (eg format, mode of administration) and outcomes for the identified study. Abstracted data were compared and disagreements resolved by discussion.
| Study and evidence quality appraisal
Both reviewers independently assessed the methodological quality using the Cochrane Effective Practice and Organization of Care
Group's (EPOC) risk of bias criteria. 34 
| Decision aid quality appraisal
The quality of the decision aid evaluated in the included study was assessed by the primary and secondary reviewers using the 2005 version of the International Patient Decision Aid Standards (IPDAS) checklist. 35 This checklist includes items in the Content domain (ie the information,
probabilities, values clarification and guidance in deliberation specific to the health condition), Development domain (ie the design and development process) and Effectiveness domain (ie outcomes related to a highquality decision). 35 Because the included study did not comprise decision aids on a diagnostic test, there were 59 potentially relevant items, including supplementary items for Internet-based tools (6 items) and tools that included patient stories (3 items). On the quality appraisal form developed for this study, minor clarifications or examples were added to some checklist items to improve clarity and thus consistency in appraisal across reviewers (form available in Appendix S1). Items that could not be confidently assessed with the information available were coded as not having met the criteria. Items that were not applicable were coded as such. † We used the Flesch-Kincaid test analytics in Microsoft Word to assess the readability and reading ease (scale 0-100, higher is easier to read) of text-based decision aids. 36, 37 We chose a readability level of 8th grade or below to indicate limited reading skills IPDAS (Item 42) and to correspond with the mean reading level in the US population. 
| Analysis
We had planned to perform a meta-analysis of study results, but only one eligible study was identified.
| Environmental scan (Part II)

| Inclusion and exclusion criteria
For the environmental scan, we adopted all intervention inclusion and exclusion criteria used in the systematic review and imposed two further criteria, excluding decision aids not written in English and those not created by a source in the United States, for women living in the United States.
| Search strategy
We conducted four Google searches using the following search strings: (i) abortion options, (ii) abortion decision aid, (iii) medical or * Decision aids that included other pregnancy options (eg adoption and/or continuing the pregnancy) were included so long as they also compared medical and surgical early abortion 40 Additionally, the decision aid identified during the systematic review was considered for the environmental scan. All searches were conducted in February 2015.
| Screening process
The screening and full review process of Internet pages and apps is described in full in the protocol. 1 We had planned to classify tools as "eligible" or "ineligible" for inclusion, but elected to add "unclear" as a third classification due to unforeseen challenges in categorizing some of the resultant tools. We contacted two study authors for clarifying information about the study population, outcomes and intervention.
The inter-rater reliability of eligible and ineligible classifications between the primary and secondary was calculated to be κ = 0.74, and thus exceeded our minimum requirement (0.7). For those classified as "unclear," the primary and secondary reviewers came to a decision about eligibility together.
| Data extraction
The primary reviewer used a customized form to extract data from all eligible decision aids (eg format, characteristics and source).
| Decision aid quality appraisal
The primary reviewer appraised the quality of all included decisions using the IPDAS checklist and the Flesch-Kincaid tests. The secondary and tertiary (GE) reviewers independently appraised the quality of random samples of 10% of the eligible decision aids. Inter-rater reliability for decision aid quality appraisals was calculated to be κ = 0.74 and κ = 0.85, and again exceeded our minimum requirement.
| RESULTS
| Systematic review
Altogether, 2930 unique articles were identified through database searches and other search methods. Of those articles classified as "potentially eligible" for inclusion, only one described a study that met all eligibility criteria (see Figure 1 ). This study was the randomized controlled trial identified in prior systematic reviews. 13, 21, 22 It was conducted in 2002 in the United Kingdom and randomized women to receive either a three-page paper decision aid about early abortion methods (n = 163) or a control leaflet about contraception (n = 165)
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in the waiting room before an abortion counselling consultation. We contacted the corresponding author to clarify the study outcomes and to inquire about related publications (eg study protocols, companion studies), none of which were identified.
| Decision aid impact
The included study found that women randomized to receive the decision aid had higher levels of knowledge about both methods, had more favourable scores on the Informed subscale of the Decisional Conflict Scale and expressed more positive attitudes towards medical abortion than women randomized to receive the control leaflet. No differences were found between groups in scores on the Uncertain or Effectiveness subscales of the Decisional Conflict Scale, level of anxiety, attitudes towards surgical abortion or chosen abortion method.
Although there were mixed findings about the effect of group on risk perception scores about each method, generally, women in the decision aid group had lower scores. Other study outcomes are described in the Cochrane Collaboration review of decision aids 13 and the two other systematic reviews mentioned previously.
21,22
| Decision aid quality appraisal
The decision aid met 5 of 23 IPDAS criteria for the Content domain of the IPDAS checklist, 11 of 20 for Development and 1 of 7 for
Effectiveness. The Flesch-Kincaid readability was calculated to be US grade level 6.9 and 62.9 reading ease.
| Study and evidence quality appraisal
Using the EPOC risk of bias criteria, the study was classified as having low risk of bias in five of nine domains (see Table 1 ). The study was classified as having high risk of bias in two domains: contamination (because randomization was at the patient level) and selective outcome reporting (because they used the entire Decisional Conflict
Scale but only reported select subscales). The risk of bias was unclear for similar baseline characteristics (because no baseline outcome Due to the identification of only one study, we were not able to use the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria to rate the quality of evidence as planned. 41 
| Environmental scan
Altogether, 434 unique tools were identified through Internet and App Store searches and other sources. Of these, 49 met eligibility criteria (see Figure 2) . Three sources referenced a decision aid, but we were unable to obtain them despite attempts to contact the authors. The vast majority of the excluded tools did not meet the definition of a decision aid (ie they failed to make the decision explicit and/or to include implicit methods to clarify values (n = 341)). 29 The decision aid identified in the systematic review did not meet eligibility criteria for the environmental scan because it was not created for women in the United States.
| Decision aid characteristics
Most of the included decision aids (n = 42) were non-interactive multipage websites that averaged 14. 
| Decision aid quality
On average, the decision aids met the criteria for 28% (n = 6) of the 23 items for Content (range: 3-12) and 0% (n = 0) of the 7 items for
Effectiveness domains (see Figure 1 ). Due to the nature of the included decision aids, the number of applicable items in the Development domain varied from 18 to 27, with an average of 22% (n = 5) of items met (range: 2-11). Table 2 provides an overview of the average scores (and ranges) for different types of decision aids. A table of scores by each decision aid is available upon request.
The decision aids met more IPDAS items in the Content and
Development domains than in the Effectiveness domain, as described in Table 3 with clarifying comments.
| DISCUSSION
This systematic review and environmental scan found that very limited research has examined the impact of early abortion method decision aids, and although many are highly accessible, their quality scores are suboptimal. The low scores can be attributed, in part, to many decision aids describing method features inconsistently and with unequal detail, and presenting information in a disorganized fashion, potentially undermining perceptions of balance among users 42 and impeding values-consistent decision making. This is likely exacerbated among women with low literacy given that the majority of decision aids did not meet readability standards. 38 The poor quality of existing early abortion methods decision aids not only represents a lost opportunity for supporting women's decision making, but may also affect their care experiences. 
T A B L E 2 Average International Patient Decision Aid Standards scores for different types of decision aids T A B L E 3 Number of decision aids that met each International Patient Decision Aid Standards (IPDAS) criteria
IPDAS criteria n Comments
Content
Describe the health condition 32/49 Sometimes failed to explain that abortion is performed to end a pregnancy.
List the options 49/49
List the option of doing nothing 18/49 Majority did not list the alternative options (ie adoption or continuing the pregnancy).
Describe the natural course without options 6/49 Few included information about the process of continuing the pregnancy. The risk of having an abortion was often described in relative terms and the "risk" was not defined (eg "far less than the risk of carrying a pregnancy and giving birth")
Use both positive and negative frames 0/49 Frequently gave success or failure rates, but rarely provided both.
Describe the procedures and outcomes to help patients imagine what it is like to experience their physical, emotional and social effects 17/49 All included some description of the methods' physical effects, but often omitted the emotional and/or social effects of one or both methods. 44 This exchange may also lead women to opt for the alternative method, potentially inconveniencing both the patient and clinic with additional costs and logistical burdens that could have been avoided.
By partnering with women and health professionals (ie end-users) to understand their decision support priorities (eg optimal information content, presentation and delivery), there is significant opportunity to develop a more quality, relevant and sustainable [45] [46] [47] early abortion method decision aid to promote patient-centred and efficient abortion care. 48 This study has implications for the current debate on decision aid certification. [49] [50] [51] Our finding that, for this topic, decision aids produced by entities without specialist expertise in decision aid design predominate suggests that a certification approach that encompasses only tools produced by specialist developers may miss most of the decision aids accessible to patients via the Internet or other channels. Although reviewing all accessible decision aids for certification is clearly unrealistic, we recommend attention be paid to strategies for supporting patients to seek and recognize high-quality, certified decision aids, and to understand the reasons for their superiority.
Furthermore, our finding that most of the decision aids met limited criteria on the 64-item IPDAS checklist suggests discordance between the priorities of subject matter experts and non-specialist developers.
A certification process that adopts more parsimonious quality criteria, such as the IPDAS minimum standards, 52 may be the most suitable for ensuring decision aids achieve acceptable quality but can still be tailored to reflect real-world needs. 53 Simultaneously, efforts to facilitate non-specialist developers' understanding of best practice standards for decision development and evaluation, and to encourage submission of decision aids for review and certification are warranted.
There are four main limitations of this study. First, because our focus was on understanding the early abortion method decision aid landscape for women in the United States, our systematic review excluded studies published before 2000 and thus may have omitted studies conducted earlier in countries with a longer history of performing medical abortion. Second, because we elected not to contact decision aid developers to solicit further information about development and evaluation processes, we may have underestimated the quality of some decision aids on these IPDAS domains. Third, because it was the most comprehensive, we adopted the 64-item IPDAS checklist for decision aid appraisal. To our knowledge, this checklist has not previously been used to appraise decision aids developed by non-specialists and thus may be less well suited to accurately capture the strengths and weaknesses of these tools. Lastly, by excluding studies evaluating decision coaching without an accompanying decision aid, we were unable to investigate the impact of different approaches to decision support in this context.
These limitations are, however, balanced by several strengths.
First, we adopted an environmental scan methodology in addition to the more traditional systematic review, which proved essential for reliably understanding the current decision aid landscape in this area.
We highly recommend that an environmental scan methodology be adopted more widely in attempts to understand the resources or interventions available to patients. Second, unlike a prior study that adopted an environmental scan, 54 our methodology purposefully sought to identify tools that met the Cochrane definition of a decision aid, whether developed by specialists or non-specialists. This prior study started with a baseline understanding of a decision aid and included only those tools that had a certain focus (ie prenatal testing), which likely missed some of the decision aids created by non-specialists.
Third, we used reliable screening and appraisal tools for the systematic review and environmental scan, evidenced by the adequate/high agreement between independent reviewers. T A B L E 3 (Continued)
| CONCLUSIONS
